Novel Therapeutic Targets

Unlocking intrinsically disordered proteins (IDPs), disease drivers up to now considered intractable by the industry, to bring disruptive therapies into patients.

Proprietary Technology

Our Platform delivers drug candidates that modulate the function of IDPs by retaining them in an inactive, disordered state, activating their degradation by cells’ intrinsic machinery.

Unmet Medical Needs

Breakthrough treatments for incurable diseases, including cancer and beyond.